StockStory.org on MSN
Q4 patient monitoring earnings review: First prize goes to iRhythm (NASDAQ:IRTC)
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes.
Samsung's Exynos 2600 is the world's first 2nm smartphone chip, and that's genuinely impressive. It's just not enough to outrun Qualcomm's Snapdragon 8 Elite Gen 5 in battery efficiency.
Medical devices using AI were rarely indicated for children and were limited to a few specialties. Pediatric devices faced ...
We tested Garmin’s GPS-enabled fitness trackers and found the perfect picks for casual hikers, backcountry skiers, and more.
After making stews, soups and chili with seven of the most popular slow cookers you can buy, we found two we’d recommend to ...
Experience From Brazilian and Australian Clinical Trials Positions the Company to Submit Investigational Device Exemption (IDE) to FDA for Novel CBGM Technology in Q2 2026RUTHERFORD, N.J., March 27, ...
There are always a few reasons people give for not buying a foldable phone. Some — price, battery life, camera quality — are ...
As nanomaterials gain commercial traction, they have the potential to revolutionize medicine, aerospace, and 3D printing, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results